303
Views
81
CrossRef citations to date
0
Altmetric
Perspectives

Gut microbiota–derived short-chain fatty acids and kidney diseases

, &
Pages 3531-3542 | Published online: 11 Dec 2017

References

  • Aguilar-NascimentoJESalomaoABNochiRJJrNascimentoMNeves JdeSIntraluminal injection of short chain fatty acids diminishes intestinal mucosa injury in experimental ischemia-reperfusionActa Cir Bras2006211 21 2516491218
  • Andrade-OliveiraVAmanoMTCorrea-CostaMGut bacteria products prevent AKI induced by ischemia-reperfusionJ Am Soc Nephrol2015268 1877 188825589612
  • BindelsLBPorporatoPDewulfEMGut microbiota-derived propionate reduces cancer cell proliferation in the liverBr J Cancer20121078 1337 134422976799
  • VaziriNDZhaoYYPahlMVAltered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatmentNephrol Dial Transpl2016315 737 746
  • VaziriNDYuanJNorrisKRole of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney diseaseAm J Nephrol2013371 1 623258127
  • MoraesCFouqueDAmaralACMafraDTrimethylamine N-oxide from gut microbiota in chronic kidney disease patients: focus on dietJ Ren Nutr2015256 459 46526235933
  • RamezaniAMassyZAMeijersBEvenepoelPVanholderRRajDSRole of the gut microbiome in uremia: a potential therapeutic targetAm J Kidney Dis2016673 483 49826590448
  • Diaz HeijtzRWangSAnuarFNormal gut microbiota modulates brain development and behaviorProc Natl Acad Sci U S A20111087 3047 305221282636
  • Vijay-KumarMAitkenJDCarvalhoFAMetabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5Science20103285975 228 23120203013
  • UronisJMMuhlbauerMHerfarthHHRubinasTCJonesGSJobinCModulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibilityPLoS One200946 e602619551144
  • PaolaMDFilippoCDCavalieriDImpact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural AfricaProc Natl Acad Sci U S A201010733 1469120679230
  • LinMYde ZoeteMRvan PuttenJPStrijbisKRedirection of epithelial immune responses by short-chain fatty acids through inhibition of histone deacetylasesFront Immunol20156 55426579129
  • MaslowskiKendle MThe role of GPR43 in the immune system: a novel connection between diet, gut microbiota and immune function Available from: Unsworks.unsw.edu.auAccessed September 1, 2017
  • NymanMFermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructoseBr J Nutr200287Suppl 2 S163 S16812088514
  • KotzampassiKGiamarellosbourboulisEJStavrouGObesity as a consequence of gut bacteria and diet interactionsISRN Obes20142014196 65189524977101
  • WongJMde SouzaRKendallCWEmamAJenkinsDJColonic health: fermentation and short chain fatty acidsJ Clin Gastroenterol2006403 235 24316633129
  • PomareEWBranchWJCummingsJHCarbohydrate fermentation in the human colon and its relation to acetate concentrations in venous bloodJ Clin Invest1985755 1448 14543998144
  • AdomDNieDRegulation of autophagy by short chain fatty acids in colon cancer cellsBaillyYAutophagy – A Double-Edged Sword – Cell Survival or DeathInTech2013
  • OrrhageKNordCEFactors controlling the bacterial colonization of the intestine in breastfed infantsActa Paediatr199988430 47 57
  • KohADe VadderFKovatcheva-DatcharyPBackhedFFrom dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolitesCell20161656 1332 134527259147
  • UlvenTShort-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targetsFront Endocrinol20123 111
  • DewulfEMGeQBindelsLBEvaluation of the relationship between GPR43 and adiposity in humanNutr Metabol2012101 11
  • TangYChenYJiangHRobbinsGTNieDG-protein-coupled receptor for short-chain fatty acids suppresses colon cancerInt J Cancer20111284 847 85620979106
  • KarakiSMitsuiRHayashiHShort-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestineCell Tissue Res20063243 353 36016453106
  • NilssonNEKotarskyKOwmanCOldeBIdentification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acidsBiochem Biophys Res Commun20033034 1047 105212684041
  • PluznickJLProtzkoRJGevorgyanHOlfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulationProc Natl Acad Sci U S A201311011 4410 441523401498
  • VinoloMARodriguesHGNachbarRTCuriRRegulation of inflammation by short chain fatty acidsNutrients2011310 858 87622254083
  • FlegelCManteniotisSOstholdSHattHGisselmannGExpression profile of ectopic olfactory receptors determined by deep sequencingPLoS One201382 e5536823405139
  • SinghNGuravASivaprakasamSActivation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesisImmunity2014401 128 13924412617
  • ThangarajuMCresciGALiuKGPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colonCancer Res2009697 2826 283219276343
  • WandersDGraffECJuddRLEffects of high fat diet on GPR109A and GPR81 gene expressionBiochem Biophys Res Commun20124252 278 28322842580
  • IngersollMAPotteauxSAlvarezDHutchisonSBVanRNRandolphGJNiacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosisImmunobiology20122175 548 55721798616
  • HuangWZhouLGuoHXuYXuYThe role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory responseMetabolism201768 20 3028183450
  • TanJMcKenzieCPotamitisMThorburnANMackayCRMaciaLThe role of short-chain fatty acids in health and diseaseAdv Immunol2014121 91 11924388214
  • KimCHParkJKimMGut microbiota-derived short-chain fatty acids, T cells, and inflammationImmune Netw2014146 277 28825550694
  • MaslowskiKMVieiraATNgARegulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43Nature20094617268 1282 128619865172
  • TrompetteAGollwitzerESYadavaKGut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesisNat Med2014202 159 16624390308
  • YamashitaHFujisawaKItoEImprovement of obesity and glucose tolerance by acetate in type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) ratsBiosci Biotechnol Biochem2014715 1236 1243
  • BerggrenAMNymanEMLundquistIBjorckIMInfluence of orally and rectally administered propionate on cholesterol and glucose metabolism in obese ratsBr J Nutr1996762 287 2948813902
  • BouterKEvan RaalteDHGroenAKNieuwdorpMRole of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunctionGastroenterology20171527 1671 167828192102
  • ToppingDLCliftonPMShort-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharidesPhysiol Rev2001813 1031 106411427691
  • StoddartLASmithNJMilliganGInternational Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functionsPharmacol Rev2008604 405 41719047536
  • VriezeAVan NoodEHollemanFTransfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndromeGastroenterology20121434 913.e7 916.e722728514
  • UdayappanSDHartstraAVDallinga-ThieGMNieuwdorpMIntestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitusClin Exp Immunol20141771 2424528224
  • ZaibiMSStockerCJO’DowdJRoles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acidsFEBS Lett201058411 2381 238620399779
  • HongYHNishimuraYHishikawaDAcetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43Endocrinology200514612 5092 509916123168
  • GeHLiXWeiszmannJActivation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acidsEndocrinology20081499 4519 452618499755
  • DelzenneNMCaniPDEverardANeyrinckAMGut microorganisms as promising targets for the management of type 2 diabetesDiabetologia20155810 2206 221726224102
  • ChambersESViardotAPsichasAEffects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adultsGut20156411 1744 175425500202
  • ParkYSubarAFHollenbeckASchatzkinADietary fiber intake and mortality in the NIH-AARP diet and health studyArch Int Med201117112 1061 106821321288
  • TolhurstGHeffronHLamYSShort-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2Diabetes2012612 364 37122190648
  • RozengurtNWuSVChenMCHuangCSterniniCRozengurtEColocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colonAm J Physiol Gastrointest Liver Physiol20062915 G792 G80216728727
  • FreelandKRWoleverTMAcute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alphaBr J Nutr20101033 460 46619818198
  • PlaisanciéPDumoulinVChayvialleJACuberJCLuminal peptide YY-releasing factors in the isolated vascularly perfused rat colonJ Endocrinol19971513 421 429
  • SamuelBSShaitoAMotoikeTEffects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41Proc Natl Acad Sci U S A200810543 16767 1677218931303
  • HolstJJThe physiology of glucagon-like peptide 1Physiol Rev2007874 1409 143917928588
  • RossSAEkoeJMIncretin agents in type 2 diabetesCan Fam Physician2010567 639 64820631270
  • KimMHKangSGParkJHYanagisawaMKimCHShort-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in miceGastroenterology20131452 396 406 e1 e1023665276
  • MorrisGBerkMCarvalhoAThe role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune diseaseMol Neurobiol2017546 4432 445127349436
  • EverardACaniPDGut microbiota and GLP-1Rev Endocri Metab Disord2014153 189 196
  • FujikawaTCoppariRLiving without insulin: the role of leptin signaling in the hypothalamusFront Neurosci20159 10825870537
  • PerryRJPengLBarryNAAcetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndromeNature20165347606 213 21727279214
  • SchwiertzATarasDSchaferKMicrobiota and SCFA in lean and overweight healthy subjectsObesity2010181 190 19519498350
  • TedelindSWestbergFKjerrulfMVidalAAnti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel diseaseWorld J Gastroenterol20071320 2826 283217569118
  • ParkJSLeeEJLeeJCKimWKKimHSAnti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathwaysInt Immunopharmacol200771 70 7717161819
  • VinoloMARodriguesHGHatanakaESatoFTSampaioSCCuriRSuppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophilsJ Nutr Biochem2011229 849 85521167700
  • LuhrsHGerkeTMullerJGButyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitisScand J Gastroenterol2002374 458 46611989838
  • MillardALMertesPMItteletDVillardFJeannessonPBernardJButyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophagesClin Exp Immunol20021302 245 25512390312
  • KaczmarczykMMMillerMJFreundGGThe health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancerMetabolism2012618 1058 106622401879
  • LiuTLiJLiuYXiaoNSuoHXieKShort-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264.7 cellsInflammation2012355 1676 168422669487
  • VoltoliniCBattersbySEtheringtonSLPetragliaFNormanJEJabbourHNA novel antiinflammatory role for the short-chain fatty acids in human laborEndocrinology20121531 395 40322186417
  • VinoloMARFergusonGJKulkarniSSCFAs induce mouse neutrophil chemotaxis through the GPR43 receptorPLoS One201166 2235 2239
  • TazoeHOtomoYKarakiSExpression of short-chain fatty acid receptor GPR41 in the human colonBiomed Res2009303 149 15619574715
  • ParkJKimMKangSGShort-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR S6K pathwayMucosal Immunol201581 80 9324917457
  • ArpaiaNCampbellCFanXMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generationNature20135047480 451 45524226773
  • SmithPMHowittMRPanikovNThe microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasisScience20133416145 569 57323828891
  • FukudaSCommensal microbe-derived butyrate induces the differentiation of colonic regulatory T cellsNature20135047480 446 45024226770
  • Le PoulELoisonCStruyfSFunctional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activationJ Biol Chem200327828 25481 2548912711604
  • VinoloMARodriguesHGHatanakaEHebedaCBFarskySHCuriRShort-chain fatty acids stimulate the migration of neutrophils to inflammatory sitesClin Sci20091179 331 33819335337
  • VaziriNDLiuSMLauWLHigh amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney diseasePLoS One2014912 e11488125490712
  • GalvezJRodriguez-CabezasMEZarzueloAEffects of dietary fiber on inflammatory bowel diseaseMol Nutr Food Res2005496 601 60815841496
  • Burger-VanPNVincentAPuimanPJThe regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protectionBiochem J20094202 211 21919228118
  • HinnebuschBFMengSWuJTArcherSYHodinRAThe effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylationJ Nutr20021325 1012 101711983830
  • HaberlandMMontgomeryRLOlsonENThe many roles of histone deacetylases in development and physiology: implications for disease and therapyNat Rev Genet2009101 32 4219065135
  • ZengHChiHMetabolic control of regulatory T cell development and functionTrends Immunol2015361 3 1225248463
  • DelgoffeGMKoleTPZhengYThe mTOR kinase differentially regulates effector and regulatory T cell lineage commitmentImmunity2009306 832 84419538929
  • SinghNThangarajuMPrasadPDBlockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylasesJ Biol Chem2010285285 27601 2760820601425
  • BradfordBEZhangMOwyangSYButyrate increases IL-23 production by stimulated dendritic cellsAm J Physiol201230312 G1384
  • FrikecheJSimonTBrissotEGregoireMGauglerBMohtyMImpact of valproic acid on dendritic cells functionImmunobiology20122177 704 71022209114
  • HovhannisyanGAroutiounianRGleiMButyrate reduces the frequency of micronuclei in human colon carcinoma cells in vitroToxicol In Vitro2009236 1028 103319539745
  • VecchiaMGCarnelos FilhoMFellipeCRCuriRNewsholmeEAAcetate and propionate potentiate the antiproliferative effect of butyrate on RBL-2H3 growthGen Pharmacol1997295 725 7289347317
  • SakataTvon EngelhardtWStimulatory effect of short chain fatty acids on the epithelial cell proliferation in rat large intestineComp Biochem Physiol A Comp Physiol1983742 459 4626131789
  • PluznickJA novel SCFA receptor, the microbiota, and blood pressure regulationGut Microbes201452 202 20724429443
  • PluznickJLGut microbiota in renal physiology: focus on short-chain fatty acids and their receptorsKidney Int2016906 1191 119827575555
  • PluznickJLMicrobial short-chain fatty acids and blood pressure regulationCurr Hypertens Rep2017194 2528315048
  • NehraVAllenJMMailingLJKashyapPCWoodsJAGut microbiota: modulation of host physiology in obesityPhysiology2016315 327 33527511459
  • FelizardoRJCastoldiAAndrade-OliveiraVCamaraNOThe microbiota and chronic kidney diseases: a double-edged swordClin Transl Immunology201656 e8627757226
  • RamezaniARajDSThe gut microbiome, kidney disease, and targeted interventionsJ Am Soc Nephrol2014254 657 67024231662
  • VaziriNDWongJPahlMChronic kidney disease alters intestinal microbial floraKidney Int2013832 308 31522992469
  • WongJPicenoYMDesantisTZPahlMAndersenGLVaziriNDExpansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRDAm J Nephrol2014393 230 23724643131
  • AndersHJAndersenKStecherBThe intestinal microbiota, a leaky gut, and abnormal immunity in kidney diseaseKidney Int2013836 1010 101623325079
  • PoesenRClaesKEvenepoelPMicrobiota-derived phenylacetylglutamine associates with overall mortality and cardiovascu-lar disease in patients with CKDJ Am SocNephrol20162711 3479 3487
  • PoesenRWindeyKNevenEThe influence of CKD on colonic microbial metabolismJ Am Soc Nephrol2016275 1389 139926400570
  • BammensBEvenepoelPKeuleersHVerbekeKVanrenterghemYFree serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patientsKidney Int2006696 1081 108716421516
  • MeijersBKBammensBDe MoorBVerbekeKVanrenterghemYEvenepoelPFree p-cresol is associated with cardiovascular disease in hemodialysis patientsKidney Int20087310 1174 118018305466
  • SirichTLPlummerNSGardnerCDHostetterTHMeyerTWEffect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patientsClin J Am Soc Nephrol201499 1603 161025147155
  • UedaHShibaharaNTakagiSInoueTKatsuokaYAST-120 treatment in pre-dialysis period affects the prognosis in patients on hemodialysisRen Fail2008309 856 86018925523
  • SchulmanGAgarwalRAcharyaMBerlTBlumenthalSKopytNA multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKDAm J Kidney Dis2006474 565 57716564934
  • PahlMVVaziriNDThe chronic kidney sisease – colonic axisSemin Dial2015285 459 46325855516
  • WangHZhangWZuoLBifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injuryBr J Nutr201310911 199023122253
  • MachadoRAConstantino LdeSTomasiCDSodium butyrate decreases the activation of NF-kappaB reducing inflammation and oxidative damage in the kidney of rats subjected to contrast-induced nephropathyNephrol Dial Transplant2012278 3136 314022273669
  • SunXZhangBHongXZhangXKongXHistone deacetylase inhibitor, sodium butyrate, attenuates gentamicin-induced nephrotoxicity by increasing prohibitin protein expression in ratsEur J Pharmacol20137071–3 147 15423528351
  • Abdul HamidZBudinSBWen JieNHamidAHusainKMohamedJNephroprotective effects of Zingiber zerumbet Smith ethyl acetate extract against paracetamol-induced nephrotoxicity and oxidative stress in ratsJ Zhejiang Univ Sci B2012133 176 18522374609
  • NiwaTRole of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120Ther Apher Dial2011152 120 12421426500
  • KhanSJenaGSodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-beta1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic ratsFood Chem Toxicol201473 127 13925158305
  • MarquesFZNelsonEMChuPYHigh fibre diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in DOCA-salt hypertensive miceCirculation201713510 964 97727927713
  • ParkJGoergenCJHogenEschHKimCHChronically elevated levels of short-chain fatty acids induce T cell-mediated ureteritis and hydronephrosisJ Immunol20161965 2388 240026819206
  • ZumbrunSDMelton-CelsaARSmithMAGilbreathJJMerrellDSO’BrienADDietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and diseaseProc Natl Acad Sci U S A201311023 E2126 E213323690602
  • ZumbrunSDMelton-CelsaARO’BrienADWhen a healthy diet turns deadlyGut Microbes201451 40 4323989728
  • ShakeelMRecent advances in understanding the role of oxidative stress in diabetic neuropathyDiabetes Metab Syndr201594 373 37825470637
  • HuangWGuoHLDengXShort-chain fatty acids inhibit oxidative stress and inflammation in mesangial cells induced by high glucose and lipopolysaccharideExp Clin Endocrinol Diabetes20171252 98 10528049222
  • MatsumotoNRileySFraserDButyrate modulates TGF-beta1 generation and function: potential renal benefit for Acacia(sen) SUPERGUM (gum arabic)?Kidney Int2006692 257 26516408114
  • IslamMBurkeJFMcgowanTAEffect of anti-transforming growth factor-βbgr antibodies in cyclosporine-induced renal dysfunctionKidney Int2001592 49811168932
  • IsakaYTsujieMAndoYTransforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstructionKidney Int2000585 1885 189211044208
  • PetersHBorderWANobleNATargeting TGF-βbgr overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockadeKidney Int1998545 1570 15809844133
  • RiveraMNHaberDAWilms’ tumour: connecting tumorigenesis and organ development in the kidneyNat Rev Cancer200559 699 71216110318
  • TanWChenYAnPSodium butyrate-induced histone hyperacetylation up-regulating WT1 expression in porcine kidney fibroblastsBiotechnol Lett2015376 1195 120225700826